Eric Karas sold $255K of ARS Pharmaceuticals (SPRY)

Executed Jul 1 2025, disclosed Jul 3 2025, 2 days later.

Value, as filed

$255K

15,000 sh × $16.99

Executed

Jul 1 2025

the trade date, as filed

Disclosed

Jul 3 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

EK Eric Karas Chief Commercial Officer profile →

Eric Karas (Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in SPRY. The largest single filing was $250K of SPRY (25,000 sh × $10.00, as filed), executed Jun 12.

The name

SPRY SPRY SPRY · 38 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Eric Karas in SPRY

SPRYSALE ARS Pharmaceuticals, Inc. $250K
25,000 sh × $10.00
Exec Jun 12
Filed Jun 12 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $240K
15,000 sh × $16.00
Exec Jun 18 2025
Filed Jun 20 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $140K
10,000 sh × $14.00
Exec Mar 20 2025
Filed Mar 21 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $140K
10,000 sh × $14.00
Exec Sep 18 2024
Filed Sep 19 2024 · 5:30 PM ET